These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6945060)

  • 21. [Present status of chemotherapy in ALL and CLL].
    Ogawa M
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1882-7. PubMed ID: 6964032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia.
    Tsimberidou AM; Kantarjian HM; Cortes J; Thomas DA; Faderl S; Garcia-Manero G; Verstovsek S; Ferrajoli A; Wierda W; Alvarado Y; O'Brien SM; Albitar M; Keating MJ; Giles FJ
    Cancer; 2003 Apr; 97(7):1711-20. PubMed ID: 12655528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase III study of intermittent carmustine (BCNU), cyclophosphamide, and prednisone versus intermittent melphalan and prednisone in myeloma.
    Abramson N; Lurie P; Mietlowski WL; Schilling A; Bennett JM; Horton J
    Cancer Treat Rep; 1982 Jun; 66(6):1273-7. PubMed ID: 7044535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doxorubicin and cisplatin therapy in children with neuroblastoma resistant to conventional therapy: a Southwest Oncology Group Study.
    Nitschke R; Starling K; Lui VK; Pullen J
    Cancer Treat Rep; 1981; 65(11-12):1105-8. PubMed ID: 7028253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remission maintenance of acute nonlymphoblastic leukemia with BCNU (NSC-409962) and cyclophosphamide (NSC-26271).
    Manaster J; Cowan DH; Curtis JE; Hasselback R; Bergsagel DE
    Cancer Chemother Rep; 1975; 59(3):537-45. PubMed ID: 1060509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].
    Liu Y; Ke XY; Ma J; Shen ZX; Zhang XH; Du X; Zhao YM; Lv JQ; Zhan ZM; Zeng XY; Xu XH; Lu ZS
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):706-8. PubMed ID: 17274381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
    Hawkins DS; Felgenhauer J; Park J; Kreissman S; Thomson B; Douglas J; Rowley SD; Gooley T; Sanders JE; Pendergrass TW
    Cancer; 2002 Sep; 95(6):1354-65. PubMed ID: 12216105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing the dosage of vincristine: a clinical and pharmacokinetic study of continuous-infusion vincristine in children with central nervous system tumors.
    Kellie SJ; Koopmans P; Earl J; Nath C; Roebuck D; Uges DR; De Graaf SS
    Cancer; 2004 Jun; 100(12):2637-43. PubMed ID: 15197807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
    Miser JS; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Grier HE
    J Clin Oncol; 2004 Jul; 22(14):2873-6. PubMed ID: 15254055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia: a Children's Cancer Group Study.
    Heath JA; Steinherz PG; Altman A; Sather H; Jhanwar S; Halpern S; Pieters R; Shah N; Steinherz L; Tannous R; Terry W; Trigg ME;
    J Clin Oncol; 2003 Apr; 21(8):1612-7. PubMed ID: 12697887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination chemotherapy with the M-2 protocol (BCNU, cyclophosphamide, vincristine, melphalan, and prednisone) for chronic lymphocytic leukemia (stages III and IV).
    Case DC; Porensky RS; Fanning JP
    Oncology; 1985; 42(6):350-3. PubMed ID: 4069549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The study of VENP therapy for acute lymphocytic leukemia (author's transl)].
    Yoshikawa H; Maruo K; Ichiniya M; Yamada H; Masaoka T; Takeyama H; Kawashima K; Yamada K
    Rinsho Ketsueki; 1980 Jun; 21(6):778-84. PubMed ID: 6936564
    [No Abstract]   [Full Text] [Related]  

  • 34. Low response rate to 5 aza-cytidine, vincristine, and prednisone therapy in previously treated childhood acute nonlymphocytic leukemia: a Southwest Oncology Group Study.
    Nitschke R; Land V; Steuber CP; Ragab AH
    Am J Pediatr Hematol Oncol; 1981; 3(3):307-9. PubMed ID: 6169289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone).
    Kempin S; Lee BJ; Thaler HT; Koziner B; Hecht S; Gee T; Arlin Z; Little C; Straus D; Reich L; Phillips E; Al-Mondhiry H; Dowling M; Mayer K; Clarkson B
    Blood; 1982 Nov; 60(5):1110-21. PubMed ID: 6751436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimum time sequence for the administration of vincristine and cyclophosphamide in vivo.
    Razek A; Vietti T; Valeriote F
    Cancer Res; 1974 Aug; 34(8):1857-61. PubMed ID: 4842737
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of histiocytic and mixed lymphomas: a comparison of two, three and four drug chemotherapy.
    Lenhard RE; Ezdinli EZ; Costello W; Bennett JM; Horton J; Amorisi EL; Stolbach L; Wolter J
    Cancer; 1978 Jul; 42(1):41-52. PubMed ID: 352507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and vincristine with two dose schedules of 5-(3,3-dimethyl-1-triazino) imidazole 4-carboxamide (DTIC) in the treatment of disseminated malignant melanoma.
    Moon JH; Gailani S; Cooper MR; Hayes DM; Rege VB; Blom J; Falkson G; Maurice P; Brunner K; Glidewell O; Holland JF
    Cancer; 1975 Feb; 35(2):368-71. PubMed ID: 1111913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of four-drug BCNU combination chemotherapy regimens.
    Durant JR; Lessner HE
    Cancer; 1973 Aug; 32(2):277-85. PubMed ID: 4722913
    [No Abstract]   [Full Text] [Related]  

  • 40. A Parkinson-like syndrome as side effect of chemotherapy with vincristine and adriamycin in a child with acute leukaemia.
    Boranic M; Raci F
    Biomedicine; 1979 Sep; 31(5):124-5. PubMed ID: 292457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.